12-21-2021Cross-posted from FDA Press roomDrug Given Every Two Months Rather Than Daily Pill is Important Tool in Effort to End the HIV Epidemic [On December 20, 2021], t…
11-30-2021Agencies across the federal government are involved in implementing the President’s Emergency Plan for AIDS Relief (PEPFAR), the largest commitment by any nat…
1-22-2021@US_FDA has approved Cabenuva (cabotegravir and rilpivirine), the first injectable, complete treatment regimen for people with #HIV that is administered once a …
12-7-2020As we look back on World AIDS Day 2020, our colleagues across the federal government spoke out about progress to date in our collective response to HIV and reco…
7-14-2020Cross-posted from U.S. Food and Drug Administration[On July 2, 2020], the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of antire…
6-16-2020On June 12, 2020, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to tr…
6-11-2020The U.S. Food and Drug Administration (FDA) has published new information on the OraQuick In-Home HIV Test. This is the only FDA-approved in-home HIV test.As th…
5-5-2020On May 1, 2020, the President announced that the investigational antiviral drug remdesivir has been authorized by the U.S. Food and Drug Administration for emer…
4-2-2020Cross-posted from U.S. Food and Drug AdministrationStatement from: Director - Center for Biologics Evaluation and Research (CBER), Peter Marks M.D., PhD.As par…
